AV8 Ventures | Activity | F4

Team Portfolio Raise Essays

F4/AV8 Ventures/Activity

AV8 Ventures Activity

Every public signal F4 has attached to this firm, with sources and cross-entity links.

Types

Time range

Investment

AV8 Ventures participated in Shennon Biotechnologies' Series A round on September 13, 2026, as part of a syndicate including CU Innovations and Buff Gold Ventures.

Shennon Bio

Shennon Bio AV8 Ventures

cbinsights.comSEP 13, 2026

businesswire.com

SEP 13, 2026

Exit

AV8 Ventures portfolio company Embrace had a liquidity event/exit on August 28, 2026.

Embrace

Embrace AV8 Ventures

cbinsights.comAUG 28, 2026

AUG 28, 2026

Exit

AV8 Ventures portfolio company Embrace, a mobile observability platform, was acquired by Palo Alto Networks. The deal was announced July 21, 2026 and closed August 27, 2026. AV8 had participated in Embrace's $45M Series B in October 2021.

Embrace

Embrace AV8 Ventures

seedtable.comJUL 21, 2026

JUL 21, 2026

4 investments· JAN 2025 – JAN 2026Show all

Investment

Co-invested in Think Bioscience's $55M Series A for drug discovery platform with AI.

Think Bioscience

Think Bioscience AV8 Ventures

startupintros.comJAN 2026

JAN 2026

Investment

Participated in Recraft's $30M Series B for AI-powered design platform.

Recraft

Recraft AV8 Ventures

startupintros.comMAY 2025

MAY 2025

Investment

Co-invested in Hydrolix's $80M Series C for log data analytics and management.

Hydrolix

Hydrolix AV8 Ventures

startupintros.comAPR 2025

APR 2025

Investment

Co-invested in Olé Life's $13M Series B for AI-powered digital insurance in Latin America.

Olé Life

Olé Life AV8 Ventures

latamlist.comJAN 2025

JAN 2025